Thermo Fisher Scientific

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

Contact Info:

Thermo Fisher Scientific
168 3rd Ave
Waltham, MA USA 02451
Phone: 800-678-5599
www.thermofisher.com

Content by Thermo Fisher Scientific:

Inside the Lab Technology and innovation

From NGS Naive to Fully Accredited

12/06/2024 | Jessica Allerton | 4 min read

Cork University Hospital's transformation in precision oncology services

Inside the Lab Technology and innovation

Comprehensive Genomic Profiling with the Oncomine Comprehensive Assay Plus

11/19/2024 | Sponsored by Thermo Fisher Scientific | 4 min read

The all-in-one CGP research test from one vendor with results in as little as three days

Inside the Lab Technology and innovation

Moving Forward with Multiplexing

10/04/2024 | Jessica Allerton | 3 min read

Improved scanning and processing of stained multiplexed tissue samples with the Invitrogen™ EVOS™ S1000 Spatial Imaging System

Diagnostics Liquid biopsy

Advancements in Liquid Biopsy Next-Generation Sequencing for Precision Oncology

08/08/2024 | Gary Pestano, PhD | 6 min read

Applications, challenges, and future directions of molecular testing for identifying targetable genetic alterations

Diagnostics Companion diagnostics

Timing Matters, and Liquid is Part of the Future

06/14/2024 | Sponsored by Thermo Fisher Scientific | 6 min read

The importance of timely genomic profiling in NSCLC: a synopsis of an Educational Symposium at European Lung Cancer Conference (ELCC) 2024

Diagnostics Companion diagnostics

Precision Medicine Pioneers

05/09/2024 | Luca Quagliata

Towards a world where NGS-based companion diagnostics are available, in house, for every new cancer therapy and every patient

Diagnostics Companion diagnostics

Precision Pathways

02/08/2024 | Luca Quagliata | 4 min read

Towards a world where NGS-based companion diagnostics are available, in house, for every new cancer therapy and every patient

Diagnostics Companion diagnostics

The Story is Still Being Written

12/05/2023 | Sponsored by Thermo Fisher Scientific | 5 min read

The ever-developing tale of companion diagnostic tests in precision oncology

Inside the Lab Technology and innovation

A Tradeoff Decision

06/14/2023 | Sponsored by Thermo Fisher Scientific | 7 min read

How do we decide which NGS technology is the best for detecting fusion variants?

Subspecialties Oncology

Rapid, Reliable Results

12/06/2022 | Sponsored by Thermo Fisher Scientific | 4 min read

Lung cancer patients can’t always wait for treatment – so rapid in-house NGS can facilitate precision therapy fast

Be Sure: LC-MS IVD Performance for Confident LDT Results

12/01/2020 | Contributed by Thermo Fisher Scientific

Explore the performance of Thermo Scientific™ triple quadrupole LC-MS systems for the analysis of clinically relevant compounds, including steroids.

Be Sure: Exemplary Performance Data for Immunosuppressants

12/01/2020 | Contributed by Thermo Fisher Scientific

Are you expected to deliver consistent, reliable results, faster?

Diagnostics Screening and monitoring

Five Reasons to implement LC-MS platforms for your laboratory developed tests

06/16/2020 | Contributed by Thermo Fisher Scientific

Implementing LC-MS requires sufficient justification and commitment of resources but can have a very positive impact on clinical and business goals.

Diagnostics Clinical care

Be Sure, Today and Tomorrow—LC-MS in Clinical Research

06/16/2020 | Contributed by Thermo Fisher Scientific

White Paper: Be Sure, Today and Tomorrow—LC-MS in Clinical Research.

Inside the Lab Oncology

Oncomine Dx Target Test – an IVD NGS solution for every lab

02/20/2019 | Contributed by Thermo Fisher Scientific

With the ongoing development of precision oncology and more and more biomarkers entering routine clinical testing...

Tomorrow’s quantitation: increased robustness for quantitation of immunosuppressant drugs in blood with the TSQ Fortis MS for clinical research

11/29/2018 | Contributed by Thermo Fisher Scientific

Development of a robust, reliable, and reproducible workflow solution for the analysis and quantitation of immunosuppressant drugs in blood.

Expert outlook: Addressing current trends and challenges in clinical research with mass spectrometry

06/22/2018 | Contributed by Thermo Fisher Scientific

The healthcare industry looks toward new solutions to provide better outcomes at lower costs.

Thermo Scientific Excelsior Tissue Processors offer performance, safety and savings for Torbay Hospital.

07/02/2015 | Contributed by Thermo Fisher Scientific

Torbay Hospital is a leading screening centre for bowel cancer and a regional training centre for NHS consultants. The efficiency of Thermo Fisher™ Excelsior™ tissue processors helps the hospital keep up with the increased demand and meet targeted turnaround times

Automated Dried Spot Analysis with the Transcend DSX-1 System

11/16/2021 | Contributed by Thermo Fisher Scientific

Experience the advantages of dried spot analysis without all the cumbersome manual steps.

Be Sure: LC-MS Medical Devices for In Vitro Diagnostic Use

12/01/2020 | Contributed by Thermo Fisher Scientific

Our family of liquid chromatography mass spectrometry instruments for in vitro diagnostics provides clinical labs with consistent reliable results.

Reduce specimen identification errors while improving laboratory efficiency with the Thermo Scientific™ PrintMate Cassette™ range

12/02/2015 | Contributed by Thermo Fisher Scientific

Improved Efficiency & Comfort with Thermo Scientific HistoStar Embedding Unit

11/25/2015 | Contributed by Thermo Fisher Scientific

Cryostar NX50 Cryostat Next Generation of Cryosectioning

08/26/2015 | Contributed by Thermo Fisher Scientific

Gold Standard Processing Just Got Even Better

07/01/2015 | Contributed by Thermo Fisher Scientific

Webinars on Demand

Addressing Clinical Needs in Precision Oncology with Rapid NGS: Experiences with the Oncomine Dx Express Test

06/13/2024 | Sponsored by Thermo Fisher Scientific

In this webinar, two laboratories share their journey in addressing these challenges and their decision to implement the Oncomine Dx Express Test. Explore how this rapid and automated NGS assay has empowered these laboratories to analyze challenging samples, streamline workflows, and deliver timely, high-quality genomic profiling to enhance patient care.

Diagnostics Oncology

Rapid molecular profiling is essential to optimize patient outcomes - Real-world data analysis

11/30/2023 | Sponsored by Thermo Fisher Scientific

In their retrospective study Integra Connect investigated how this behavior affects outcomes.

Diagnostics Genetics and epigenetics

Opportunities and challenges with comprehensive genomic profiling: the right solution for the right question

03/11/2021 | Sponsored by Thermo Fisher Scientific

In this webinar, our speakers will discuss the benefits of CGP and how this technique is utilized in their lab.

Diagnostics Biochemistry and molecular biology

A new day for myeloid genomic profiling: how NGS advancements are providing deeper insight with faster time to results

09/23/2020 | Sponsored by Thermo Fisher Scientific

The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.

Diagnostics Genetics and epigenetics

Hear both sides of the fusion detection story

03/26/2020 | Sponsored by Thermo Fisher Scientific

Fusion based biomarkers are becoming more and more important in precision oncology clinical research.

Diagnostics Genetics and epigenetics

Introducing New World of NGS - One Day Hands Free solution to fit in any lab

12/05/2019 | Sponsored by Thermo Fisher Scientific

Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.

Inside the Lab Oncology

NTRK fusion testing in lung cancer – another reason to implement broad molecular profiling

03/21/2019 | Sponsored by Thermo Fisher Scientific

With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue.

Outside the Lab Screening and monitoring

Determining tumour mutation burden using Oncomine Tumour Mutation Load Assay

04/18/2018 | Sponsored by Thermo Fisher Scientific

The Pathologist and Thermo Fisher Scientific are giving you the opportunity to delve into tumour mutation burden.

Inside the Lab Genetics and epigenetics

Next Generation Sequencing in NSCLC – it works, it makes sense….. its time !

03/22/2018 | Sponsored by Thermo Fisher Scientific

This webinar, will discuss the benefits of next generation sequencing (NGS) for simultaneous testing of multiple biomarkers in non-small cell lung cancer.

Inside the Lab Liquid biopsy

Advancing liquid biopsy research using next-generation sequencing: A multi-centre lung cancer cell-free DNA (cfDNA) study

01/12/2018 | Sponsored by Thermo Fisher Scientific

Tumour-specific mutations in plasma can serve as biomarkers for tumour detection, monitoring tumour response to therapies, detecting residual disease, and enabling long-term follow-up.